Solifenacin NOBEL 5 mg
Solifenacin NOBEL 5 mg is a medicine authorised by Swissmedic under authorisation number 67838. The authorisation holder is NOBEL Pharma Schweiz AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 20 May 2020 and the authorisation is valid without a time limit. ATC code G04BD08 places the medicine in the group Urologicals.
| Authorisation number | 67838 |
|---|---|
| Name | Solifenacin NOBEL 5 mg |
| Full name | Solifenacin NOBEL 5 mg, Filmtabletten |
| Authorisation holder | NOBEL Pharma Schweiz AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | G04BD08 |
| First authorisation | 20 May 2020 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Solifenacin NOBEL 5 mg, Filmtabletten | B | 20 May 2020 |
| 2 | Solifenacin NOBEL 10 mg, Filmtabletten | B | 20 May 2020 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 30 | Tablette(n) | G04BD08 | 05.02.0. | B |
| 2 | 90 | Tablette(n) | G04BD08 | 05.02.0. | B |
| 3 | 30 | Tablette(n) | G04BD08 | 05.02.0. | B |
| 4 | 90 | Tablette(n) | G04BD08 | 05.02.0. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Solifenacin NOBEL 5 mg authorised in Switzerland?
Yes. Solifenacin NOBEL 5 mg is authorised by Swissmedic under authorisation number 67838, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Solifenacin NOBEL 5 mg have?
Solifenacin NOBEL 5 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Solifenacin NOBEL 5 mg?
The authorisation holder is NOBEL Pharma Schweiz AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.